Ryanodine Receptor Type 2 Plays a Role in the Development of Cardiac Fibrosis under Mechanical Stretch Through TGFβ-1

Zhiwen Ding1, Jie Yuan1, Yanyan Liang2

  • 1Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital and Institute of Biomedical Sciences, Fudan University.

International Heart Journal
|November 23, 2017
PubMed

Insights

Ryanodine receptor type 2 (RyR-2) in heart cells regulates cardiac fibrosis by controlling TGFβ1 signaling. This pathway, involving mechanical stretch, promotes collagen production in fibroblasts, impacting heart disease development.

Area of Science:

  • Cardiovascular Biology
  • Cellular Signaling
  • Fibrosis Research

Background:

  • Ryanodine receptor type 2 (RyR-2) is crucial for cardiomyocyte calcium handling and cardiac hypertrophy.
  • The specific role of RyR-2 in cardiac fibrosis development during hypertrophy is not well understood.

Purpose of the Study:

  • To investigate if RyR-2 regulates transforming growth factor beta 1 (TGFβ1) in cardiomyocytes.
  • To determine the mechanism by which RyR-2 influences cardiac fibrosis via TGFβ1.

Main Methods:

  • Utilized cultured neonatal rat cardiomyocytes and cardiac fibroblasts.
  • Examined RyR-2 expression, TGFβ1 upregulation under mechanical stretch, and collagen gene expression.
  • Employed RyR-2 knockdown and TGFβ1-neutralizing antibodies for mechanistic studies.

Main Results:

  • RyR-2 was exclusively expressed in cardiomyocytes, not fibroblasts.
  • Mechanical stretch increased cardiomyocyte TGFβ1; RyR-2 knockdown suppressed this increase.
  • TGFβ1 inhibition abolished the stretch-induced collagen gene upregulation in fibroblasts.

Conclusions:

  • RyR-2 in cardiomyocytes regulates TGFβ1 expression in response to mechanical stretch.
  • TGFβ1 acts in a paracrine manner to promote collagen synthesis by cardiac fibroblasts.
  • RyR-2 contributes to cardiac fibrosis development through a TGFβ1-dependent paracrine pathway.